+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Metastatic Breast Cancer Treatment Market by Treatment Type (Biologic Targeted Therapy, Breast Surgery, Chemotherapy), End User (Clinics, Hospitals) - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968652
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Metastatic Breast Cancer Treatment Market size was estimated at USD 21.66 billion in 2023, USD 24.29 billion in 2024, and is expected to grow at a CAGR of 12.20% to reach USD 48.53 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Metastatic Breast Cancer Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Metastatic Breast Cancer Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Metastatic Breast Cancer Treatment Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., AstraZeneca PLC, Bayer AG, Biocon Limited, Eisai Co., Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., Sanofi S.A., and Sun Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Metastatic Breast Cancer Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment Type
    • Biologic Targeted Therapy
    • Breast Surgery
    • Chemotherapy
    • Hormone Therapy
    • Radiation Therapy
  • End User
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Metastatic Breast Cancer Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Metastatic Breast Cancer Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Metastatic Breast Cancer Treatment Market?
  4. What is the market share of the leading vendors in the Metastatic Breast Cancer Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Metastatic Breast Cancer Treatment Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Metastatic Breast Cancer Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing cases of breast cancers
5.1.1.2. Rise in awareness among people for metastatic breast cancer treatment
5.1.1.3. Openness to ionizing and ultraviolet radiation
5.1.2. Restraints
5.1.2.1. Costly procedures of metastatic breast cancer treatments
5.1.3. Opportunities
5.1.3.1. Robust technological advancement in the cancer treatments
5.1.3.2. Ongoing research and development in the metastatic breast cancer treatment
5.1.4. Challenges
5.1.4.1. Side effect associated with the treatment
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Metastatic Breast Cancer Treatment Market, by Treatment Type
6.1. Introduction
6.2. Biologic Targeted Therapy
6.3. Breast Surgery
6.4. Chemotherapy
6.5. Hormone Therapy
6.6. Radiation Therapy
7. Metastatic Breast Cancer Treatment Market, by End User
7.1. Introduction
7.2. Clinics
7.3. Hospitals
8. Americas Metastatic Breast Cancer Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Metastatic Breast Cancer Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Metastatic Breast Cancer Treatment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Amgen Inc.
12.1.2. AstraZeneca PLC
12.1.3. Bayer AG
12.1.4. Biocon Limited
12.1.5. Eisai Co., Ltd.
12.1.6. Eli Lilly and Company
12.1.7. F. Hoffmann-La Roche Ltd.
12.1.8. Gilead Sciences, Inc.
12.1.9. GlaxoSmithKline PLC
12.1.10. Johnson & Johnson Services, Inc.
12.1.11. Merck & Co., Inc.
12.1.12. Novartis AG
12.1.13. Pfizer Inc.
12.1.14. Sanofi S.A.
12.1.15. Sun Pharmaceutical Industries Limited
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. METASTATIC BREAST CANCER TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. METASTATIC BREAST CANCER TREATMENT MARKET DYNAMICS
FIGURE 7. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 8. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 10. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. METASTATIC BREAST CANCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. METASTATIC BREAST CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. METASTATIC BREAST CANCER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 6. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BIOLOGIC TARGETED THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY BREAST SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HORMONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 12. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. CANADA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 22. CANADA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. MEXICO METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 24. MEXICO METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 33. CHINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 34. CHINA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. INDIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 36. INDIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. JAPAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. JAPAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. THAILAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 52. THAILAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. DENMARK METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. EGYPT METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 61. EGYPT METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. FINLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. FINLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. FRANCE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. FRANCE METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. GERMANY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 67. GERMANY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. ITALY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 71. ITALY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. NORWAY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 77. NORWAY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. POLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 79. POLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. QATAR METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. QATAR METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. SPAIN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 89. SPAIN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. TURKEY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 95. TURKEY METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM METASTATIC BREAST CANCER TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. METASTATIC BREAST CANCER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 101. METASTATIC BREAST CANCER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. METASTATIC BREAST CANCER TREATMENT MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Biocon Limited
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 24.29 Billion
Forecasted Market Value ( USD ) by 2030 $ 48.53 Billion
Compound Annual Growth Rate12.2%
Regions CoveredGlobal

Related Topics

Related Reports

2024 Global Forecast for Metastatic Breast Cancer Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report - Product Image

2024 Global Forecast for Metastatic Breast Cancer Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report

  • Report
  • 132 Pages
  • Global
From
HER2Negative Metastatic Breast Cancer - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

HER2Negative Metastatic Breast Cancer - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Metastatic triple-negative breast cancer (mTNBC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Metastatic triple-negative breast cancer (mTNBC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Metastatic HER2-Positive Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Metastatic HER2-Positive Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 138 Pages
  • Global
From
Triple-negative Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Triple-negative Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 129 Pages
  • Global
From

About the Metastatic Breast Cancer Drug Market

The Metastatic Breast Cancer Drug market is a subset of the larger Breast Cancer Drug market. It is composed of drugs used to treat metastatic breast cancer, which is cancer that has spread beyond the breast to other parts of the body. These drugs are used to slow the growth of cancer cells, reduce the size of tumors, and reduce the spread of cancer. They may also be used to reduce symptoms and improve quality of life. The Metastatic Breast Cancer Drug market is highly competitive, with many companies developing and marketing drugs to treat this type of cancer. Some of the major players in the market include Pfizer, Novartis, AstraZeneca, Roche, and Merck. Other companies such as Eli Lilly, Sanofi, and Bristol-Myers Squibb also have a presence in the market. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.